Dysregulation of DNA repair pathways in a transforming growth factor α/c-myc transgenic mouse model of accelerated hepatocarcinogenesis

Laboratory Investigation

Volumn 83, Issue 5, 2003, Pages 643-654

  Hironaka, Koji ^a   Factor, Valentina M ^a   Calvisi, Diego F ^a   Conner, Elizabeth A ^a   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PEROXISOME PROLIFERATOR; TRANSFORMING GROWTH FACTOR;

ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; GENE EXPRESSION; LIVER CANCER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038137363     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000067483.89649.11     Document Type: Article

References (65)

1. Akiyama TE, Nicol CJ, Fievet C, Staels B, Ward JM, Auwerx J, Lee SS, Gonzalez FJ, and Peters JM (2001). Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: Studies with congenic mouse lines. J Biol Chem 276:39088-39093.
2. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, and Harris CC (1998a). p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4:1371-1376.
3. Ambs S, Ogunfusika MO, Merriam WG, Bennett WP, Billiar TR, and Harris CC (1998b). Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95:8823-8828.
4. Baker SM, Bronner CE, Zhang L, Plug AW, Robatzek M, Warren G, Elliott EA, Yu J, Ashley T, and Arnheim N (1995). Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82:309-319.
5. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, and Ziv Y (1998). Enhanced phosphorylation of p53 by ATM in response to DNA damage, Science 281:1674-1677.
6. Buendia MA (2000). Genetics of hepatocellular carcinoma. Semin Cancer Biol 10:185-200.
7. Buermeyer AB, Deschenes SM, Baker SM, and Liskay RM (1999). Mammalian DNA mismatch repair, Annu Rev Genet 33:533-564.
8. Cadet J, Bourdat AG, D'Ham C, Duarte V, Gasparutto D, Romieu A, and Ravanat JL (2000). Oxidative base damage to DNA: Specificity of base excision repair enzymes. Mutat Res 462:121-128.
9. Calvisi DF, Ladu S, Conner EA, Factor VM, and Thorgeirsson SS (2002). Identification of two molecular pathways of hepatocarcinogenesis in transgenic mouse models for liver cancer, Proc Am Assoc Cancer Res 43:859.
10. Cornforth MN and Bedford JS (1985). On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 227:1589-1591.
11. Critchlow SE and Jackson SP (1998). DNA end-joining: From yeast to man. Trends Biochem Sci 23:394-398.
12. Droge W (2002). Free radicals in the physiological control of cell function. Physiol Rev 82:47-95.
13. Factor VM, Jensen MR, and Thorgeirsson SS (1997). Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice. Hepatology 26:1434-1443.
14. Factor VM, Kiss A, Woitach JT, Wirth PJ, and Thorgeirsson SS (1998). Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem 273:15846-15853.
15. Floyd RA (1990). Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587-2597.
16. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, and Harris CC (1996). Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93:2442-2447.
17. Frosina G (2000). Overexpression of enzymes that repair endogenous damage to DNA, Eur J Biochem 267:2135-2149.
18. Gatei M, Shkedy D, Khanna KK, Uziel T, Shiloh Y, Pandita TK, Lavin MF, and Rotman G (2001). Ataxia-telangiectasia: Chronic activation of damage-responsive functions is reduced by alpha-lipoic acid. Oncogene 20:289-294.
19. Glassner BJ, Rasmussen LJ, Najarian MT, Posnick LM, and Samson LD (1998). Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci USA 95:9997-10002.
20. Hainaut P and Milner J (1993). Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53:4469-4473.
21. Hanahan D and Weinberg RA (2000). The hallmarks of cancer. Cell 100:57-70.
22. Hartley KO, Gell D, Smith GC, Zhang H, Divecha N, Connelly MA, Admon A, Lees-Miller SP, Anderson CW, and Jackson SP (1995). DNA-dependent protein kinase catalytic subunit: A relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82:849-856.
23. Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR, and Koi M (1995). Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res 55:3721-3725.
24. Humar B, Muller H, and Scott RJ (1997). Elevated frequency of p53-independent apoptosis after irradiation increases levels of DNA breaks in ataxia telangiectasia lymphoblasts. Int J Radiat Biol 72:257-269.
25. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, and Merlino GT (1990). TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 6:1137-1146.
26. Karran P (2000). DNA double strand break repair in mammalian cells. Curr Opin Genet Dev 10:144-150.
27. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, and Fornace AJ Jr (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597.
28. Kastan MB and Lim DS (2000). The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1:179-186.
29. Khanna KK and Jackson SP (2001). DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 27:247-254.
30. Khanna KK and Lavin MF (1993). Ionizing radiation and UV induction of p53 protein by different pathways in ataxiatelangiectasia cells. Oncogene 8:3307-3312.
31. Kolodner RD and Marsischky GT (1999). Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9:89-96.
32. Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, and Sarasin A (2000). BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 60:5548-5552.
33. Maki CG and Howley PM (1997). Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17:355-363.
34. Marnett LJ (2000). Oxyradicals and DNA damage. Carcinogenesis 21:361-370.
35. Mellon I, Rajpal DK, Koi M, Boland CR, and Champe GN (1996). Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272:557-560.
36. Menssen A and Hermeking H (2002). Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 99:6274-6279.
37. Meplan C, Richard MJ, and Hainaut P (2000). Redox signalling and transition metals in the control of the p53 pathway. Biochem Pharmacol 59:25-33.
38. Meyn MS, Strasfeld L, and Allen C (1994). Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol 66:S141-S149.
39. Mitra S, Boldogh I, Izumi T, and Hazra TK (2001). Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ Mol Mutagen 38:180-190.
40. Modrich P and Lahue R (1996). Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65:101-133.
41. Moller P and Wallin H (1998). Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat Res 410:271-290.
42. Morgan SE and Kastan MB (1997). p53 and ATM: Cell cycle, cell death, and cancer. Adv Cancer Res 71:1-25.
43. Morgan SE, Lovly C, Pandita TK, Shiloh Y, and Kastan MB (1997). Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 17:2020-2029.
44. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, and Thorgeirsson SS (1993). Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 53:1719-1723.
45. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, and Li GC (1996). Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382:551-555.
46. Otterlei M, Kavli B, Standal R, Skjelbred C, Bharati S, and Krokan HE (2000). Repair of chromosomal abasic sites in vivo involves at least three different repair pathways. EMBO J 19:5542-5551.
47. Ozturk M (1999). Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19:235-242.
48. Pfeiffer P, Goedecke W, and Obe G (2000). Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15:289-302.
49. Prolla TA, Baker SM, Harris AC, Tsao JL, Yao X, Bronner CE, Zheng B, Gordon M, Reneker J, Arnheim N, Shibata D, Bradley A, and Liskay RM (1998). Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 18:276-279.
50. Rusyn I, Denissenko MF, Wong VA, Butterworth BE, Cunningham ML, Upton PB, Thurman RG, and Swenberg JA (2000). Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. Carcinogenesis 21:2141-2145.
51. Rusyn I, Kadiiska MB, Dikalova A, Kono H, Yin M, Tsuchiya K, Mason RP, Peters JM, Gonzalez FJ, Segal BH, Holland SM, and Thurman RG (2001). Phthalates rapidly increase production of reactive oxygen species in vivo: Role of Kupffer cells. Mol Pharmacol 59:744-750.
52. Sakamoto M, Hirohashi S, and Shimosato Y (1991). Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22:172-178.
53. Santoni-Rugiu E, Jensen MR, and Thorgeirsson SS (1998). Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res 58:123-134.
54. Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, and Thorgeirsson SS (1996). Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am J Pathol 149:407-428.
55. Sargent LM, Sanderson ND, and Thorgeirsson SS (1996). Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes. Cancer Res 56:2137-2142.
56. Sargent LM, Zhou X, Keck CL, Sanderson ND, Zimonjic DB, Popescu NC, and Thorgeirsson SS (1999). Nonrandom cytogenetic alternations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-α in the liver. Am J Pathol 154:1047-1055.
57. Schar P (2001). Spontaneous DNA damage, genome instability, and cancer: When DNA replication escapes control. Cell 104:329-332.
58. Stuver SO (1998). Towards global control of liver cancer? Semin Cancer Biol 8:299-306.
59. Tan M, Li S, Swaroop M, Guan K, Oberley LW, and Sun Y (1999). Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274:12061-12066.
60. Vogelstein B and Kinzler KW (1993). The multistep nature of cancer. Trends Genet 9:138-141.
61. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, and Qin J (2000). BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939.
62. Worth L Jr, Clark S, Radman M, and Modrich P (1994). Mismatch repair proteins MutS and MutL inhibit RecAcatalyzed strand transfer between diverged DNAs. Proc Natl Acad Sci USA 91:3238-3241.
63. Ye H, Holterman AX, Yoo KW, Franks RR, and Costa RH (1999). Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Blol 19:8570-8580.
64. Yeldandi AV, Rao MS, and Reddy JK (2000). Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res 448:159-177.
65. Zhu C, Bogue MA, Lim DS, Hasty P, and Roth DB (1996). Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379-389.